Skip to main content
Premium Trial:

Request an Annual Quote

A Public Resignation

In a public resignation letter, Harvard School of Public Health professor Winston Hide says he's leaving his post as associate editor of the Elsevier journal Genomics because he "can no longer work for a system that puts profit over access to research." In a column in The Guardian, Hide says the publisher is essentially denying the developing world access to research and discoveries. "It has not been an easy decision. Some may feel that I'm grandstanding or making a futile gesture. And it may be a toxic career move," Hide says. He adds that he plans to devote whatever time he has to developing an open-access journal "that provides its work at no cost to researchers who urgently require its contents to improve their environment."

Elsevier may have beaten Hide to the punch. The publisher has agreed to make thousands of its books and journals available to institutions and researchers in more than 100 developing countries for little or no money. In a press release from Research4Life — a group of public-private partnerships Elsevier helped found — the publisher says its entire SciVerse ScienceDirect e-book collection will be included in the list of publications made available through this program.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.